131 related articles for article (PubMed ID: 10091703)
1. The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold.
Dziadulewicz EK; Brown MC; Dunstan AR; Lee W; Said NB; Garratt PJ
Bioorg Med Chem Lett; 1999 Feb; 9(3):463-8. PubMed ID: 10091703
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
[TBL] [Abstract][Full Text] [Related]
3. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers.
Alcaro MC; Vinci V; D'Ursi AM; Scrima M; Chelli M; Giuliani S; Meini S; Di Giacomo M; Colombo L; Papini AM
Bioorg Med Chem Lett; 2006 May; 16(9):2387-90. PubMed ID: 16504505
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of bradykinin B(2) receptor agonists containing constrained dipeptide mimics.
Amblard M; Daffix I; Bergé G; Calmès M; Dodey P; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Martinez J
J Med Chem; 1999 Oct; 42(20):4193-201. PubMed ID: 10514289
[TBL] [Abstract][Full Text] [Related]
6. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
8. HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats.
Bao G; Qadri F; Stauss B; Stauss H; Gohlke P; Unger T
Eur J Pharmacol; 1991 Jul; 200(1):179-82. PubMed ID: 1769370
[TBL] [Abstract][Full Text] [Related]
9. A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.
Galoppini C; Meini S; Tancredi M; Di Fenza A; Triolo A; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mazzucco S; Papini A; Rovero P
J Med Chem; 1999 Feb; 42(3):409-14. PubMed ID: 9986712
[TBL] [Abstract][Full Text] [Related]
10. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.
Wall TM; Linseman DA; Hartman JC
Eur J Pharmacol; 1996 Jun; 306(1-3):165-74. PubMed ID: 8813629
[TBL] [Abstract][Full Text] [Related]
11. Ala scan analogues of HOE 140. Synthesis and biological activities.
Quartara L; Ricci R; Meini S; Patacchini R; Giolitti A; Amadesi S; Rizzi C; Rizzi A; Varani K; Borea PA; Maggi CA; Regoli D
Eur J Med Chem; 2000 Nov; 35(11):1001-10. PubMed ID: 11137228
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140.
Kennedy KJ; Orwig KS; Dix TA; Christopher J; Jaffa AA
J Pept Res; 2002 Apr; 59(4):139-48. PubMed ID: 11972749
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus.
Ballet S; De Wachter R; Van Rompaey K; Tömböly C; Feytens D; Töth G; Quartara L; Cucchi P; Meini S; Tourwé D
J Pept Sci; 2007 Mar; 13(3):164-70. PubMed ID: 17266049
[TBL] [Abstract][Full Text] [Related]
14. Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.
Meini S; Patacchini R; Giuliani S; Lazzeri M; Turini D; Maggi CA; Lecci A
Eur J Pharmacol; 2000 Jan; 388(2):177-82. PubMed ID: 10666510
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of bradykinin B1 and B2 receptors using rat isolated vas deferens.
Scott P; Razzaque Z; Longmore J
Eur J Pharmacol; 2003 Jan; 458(3):319-25. PubMed ID: 12504789
[TBL] [Abstract][Full Text] [Related]
16. Effects of two novel non-peptide antagonists at the rabbit bradykinin B2 receptor.
Marceau F; Houle S; Bouthillier J; Said NB; Garratt PJ; Dziadulewicz EK
Peptides; 2001 Sep; 22(9):1397-402. PubMed ID: 11514020
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
Deekonda S; Rankin D; Davis P; Lai J; Porreca F; Hruby VJ
Bioorg Med Chem Lett; 2015 Oct; 25(19):4148-52. PubMed ID: 26316468
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists.
Gama Landgraf R; Sirois P; Jancar S
Eur J Pharmacol; 2003 Jan; 460(1):75-83. PubMed ID: 12535863
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade.
LeFebvre J; Shintani A; Gebretsadik T; Petro JR; Murphey LJ; Brown NJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1261-7. PubMed ID: 17182977
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
